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The mammalian Staufen proteins (Stau1 and Stau2) mediate degradation of mRNA containing
complex secondary structures in their 3’-untranslated region (UTR) through a pathway
known as Staufen-mediated mRNA decay (SMD). This pathway also involves the RNA
helicase UPF1, which is best known for its role in the nonsense-mediated mRNA decay
(NMD) pathway. Here we present a biochemical reconstitution of the recruitment and
activation of UPF1 in context of the SMD pathway. We demonstrate the involvement of UPF2,
a core NMD factor and a known activator of UPF1, in SMD. UPF2 acts as an adaptor between
Stau1 and UPF1, stimulates the catalytic activity of UPF1 and plays a central role in the
formation of an SMD-competent mRNP. Our study elucidates the molecular mechanisms of
SMD and points towards extensive cross-talk between UPF1-mediated mRNA decay path-
ways in cells.
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The fate of a messenger RNA (mRNA) in cells is heavilyinﬂuenced by the protein factors it associates withthroughout its lifetime1. Sequence and structural features
within the mRNA dictate the proteins bound to it and regulate all
aspects of its metabolism, such as processing, transport, transla-
tion and decay. In particular, the half-life of mRNA in cells is
heavily dependent on speciﬁc features, referred to as cis-acting
elements, usually present in the 3′-untranslated region (3′-UTR)
of the mRNA. These cis-acting elements are bound by trans-
acting protein factors, resulting in the assembly of an
mRNA–protein complex (mRNP) of deﬁned composition, which
in turn act as an adaptor to recruit the mRNA degradation
machinery to the transcript. Therefore, assembly of the mRNP is
a critical step in mediating decay of the target mRNA through a
speciﬁc pathway2.
The cis-acting signals for decay in eukaryotic mRNA vary from
simple linear sequences to more complex structural motifs.
Extended double-stranded (ds) RNA stretches, both within the
coding sequence and the 3′-UTR, are often recognized by the
dsRNA-binding protein Staufen3–5. While Staufen is known to be
a key mRNA transport and localization factor in Drosophila6,7,
binding of the mammalian Staufen paralogs, Stau1 and Stau2, to
inter- and intra-molecular RNA duplexes within the 3′-UTR
triggers degradation of the target mRNA8,9. This degradation
process, referred to as Staufen-mediated mRNA decay (SMD),
also relies on efﬁcient translation, and recruitment of the RNA
helicase up-frameshift 1 (UPF1) to the Staufen-binding sites
(SBS) of the target mRNA10,11.
UPF1, a multi-domain protein, is the central component of the
nonsense-mediated mRNA decay (NMD) pathway, which detects
and degrades mRNA transcripts containing a premature termi-
nation codon (PTC)12. It consists of an N-terminal cysteine-
histidine-rich (CH) domain and a C-terminal helicase core
comprising two RecA domains that encompass the nucleotide-
and RNA-binding motifs essential for catalysis (Fig. 1a)13. The
catalytic activity of UPF1 is essential for remodeling nonsense
mRNPs to facilitate their degradation and is tightly regulated by
intra- and inter-molecular interactions14–16. Interaction of the
CH domain with the RecA2 domain represses UPF1 activity,
whereas binding of the conserved NMD factor UPF2 to the CH
domain of UPF1 stimulates its activity. These intra- and inter-
molecular interactions are mutually exclusive and are responsible
for switching UPF1 from an auto-inhibited state to an activated
state by inducing a large conformational change in the helicase
upon binding to UPF2 (Supplementary Fig. 1a)17,18.
The SMD pathway was also shown to necessitate the helicase
activity of UPF119, although it was not clear how the activity is
stimulated in the context of SMD. Interestingly, Stau1 can engage
in direct protein–protein interactions with the CH domain of
UPF1, suggesting that its role in SMD might be analogous to that
of UPF2 in the NMD pathway11. Furthermore, NMD and SMD
were shown to be mutually exclusive pathways, presumably due to
the binding of the UPF1CH domain to both UPF2 and Staufen
proteins11. However, UPF2 and Staufen are considerably different
in terms of their primary structure and domain organization.
UPF2 consists of three MIF4G (middle portion of eIF4G) domains
that typically act as protein–protein interaction platforms, fol-
lowed by a natively unstructured stretch that binds to UPF1
(referred to as the UPF1-binding domain or U1BD, Fig. 1a)18,20,21.
Human Stau1 consists of four dsRNA-binding domains (dsRBDs),
termed dsRBD2–5 based on their homology with the equivalent
domains of Drosophila Staufen22,23. Of the four dsRBDs, only
dsRBD3 and 4 are capable of binding dsRNA23–26, while dsRBD5
together with a short sequence located directly N-terminal to it
(Staufen-swapping motif, SSM) is responsible for dimerization of
Stau1 (Fig. 1a)27. Dimerization of Stau1 enhances the efﬁciency of
SMD, possibly by strengthening the interaction of UPF1 with
Stau1. Notably, Stau1 lacks a distinct UPF1-binding domain as is
found in UPF2 and instead engages UPF1 using its dsRBD4 and
Tubulin-binding domains11.
In this study, we analyze the interactions between Stau1 and
UPF1 in vitro, with an aim to understand the mechanism of
recruitment and activation of UPF1 in the SMD pathway. We
found that although Stau1 mediates direct interactions with
UPF1, this is not sufﬁcient to reconstitute an mRNP. Further-
more, the binding of Stau1 does not stimulate the catalytic activity
of UPF1 in vitro. This raises the question of how UPF1 is
recruited to an SBS-mRNA and activated in the SMD pathway.
Our biochemical reconstitution experiments suggest that the core
NMD factor UPF2 plays an integral role in the SMD pathway. We
present here a mechanistic study that elucidates how UPF2
mediates the recruitment and activation of UPF1 in the context of
SMD and highlights the role of UPF2 in facilitating mRNA decay
in this pathway.
Results
Stau1 mediates weak interactions with UPF1. Since Stau1
interacts with the cis-inhibitory CH domain of UPF1, we hypo-
thesized that, akin to UPF2, Stau1 could stimulate the catalytic
activity of UPF1. To this end, we puriﬁed a UPF1 construct
encompassing its CH domain and helicase core (referred to as
UPF1 in the text, Fig. 1a) and tested its RNA-dependent ATPase
activity, in the absence and presence of full-length Stau1, using a
coupled-enzymatic assay (Fig. 1b). In this study we used the more
abundant, shorter splice isoform of UPF128 and the longer iso-
form of Stau1 (Stau163, referred to as Stau1 throughout). The
activity of UPF1 in the presence of a UPF2 construct comprising
the MIF4G3 domain and U1BD (UPF2s, Fig. 1a) was measured as
a control. As expected, UPF2s robustly stimulated the ATPase
activity of UPF1 (Fig. 1b, blue trace). However, full-length Stau1
did not enhance UPF1 activity, even when present in 10-fold
molar excess (Fig. 1b, compare yellow and purple traces). To
understand the basis of this differential effect of Stau1 and UPF2
on UPF1 activity, we performed glutathione-S-transferase (GST)-
pulldown assays to compare binding of the two proteins to the
UPF1CH domain. A stoichiometric amount of UPF2s was co-
precipitated with GST-UPF1CH, whereas the amount of Stau1
detected as being bound to GST-UPF1CH was 3.3-fold lower
(Fig. 1c, compare lanes 1 and 2). Furthermore, size-exclusion
chromatography (SEC) of a mixture of equi-molar amounts of
UPF1 and Stau1 did not yield a stable complex between the two
proteins, corroborating the fact that the association of Stau1 with
UPF1 is a weak one (Supplementary Fig. 1b). We deduce that the
interaction between Stau1 and UPF1 is not strong enough to elicit
the large conformational change in UPF1 that is necessary for
stimulation of its catalytic activity17.
UPF2 bridges the interaction between Stau1 and UPF1. The
inability of Stau1 to form a stable complex with UPF1 also raises
the question of how UPF1 is speciﬁcally recruited to SBS elements
in the 3′-UTR of target mRNAs. UPF1 preferentially binds single-
stranded (ss) RNA, suggesting that its recruitment to the struc-
tured RNA of the SBS has to be mediated by another protein
factor, which either binds the SBS directly or interacts strongly
with Stau1. Furthermore, once recruited to the SBS, the helicase
activity of UPF1 has to be stimulated to facilitate unwinding of
the dsRNA and subsequent degradation. Since UPF2 is the only
known activator of UPF1, we proceeded to test if its presence
enhances the Stau1–UPF1 interaction. We carried out pulldown
assays of GST-tagged UPF1 and UPF1CH constructs with Stau1,
in the absence and presence of UPF2 (Fig. 1d). The addition of
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UPF2 signiﬁcantly increased the amount of Stau1 that is co-
precipitated with UPF1 (3.3- and 2.3-fold increase for UPF1 and
UPF1CH, respectively, Fig. 1d, compare lanes 2 and 3 and 4 and
5). We reasoned that UPF2 could augment the binding of Stau1
to UPF1 in two ways: either by acting as an adaptor between
Stau1 and UPF1 or by stabilizing an open, active conformation of
UPF1 that preferentially binds Stau1. To determine if Stau1
preferentially binds the active form of UPF1, we tested its inter-
action with a constitutively active mutant, UPF1(F192E).
We did not observe stronger binding of Stau1 to activated
UPF1, suggesting that the enhancement of Stau1 binding to
UPF1 in the presence of UPF2 is not due to selective binding of
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We next tested if UPF2 functions as an adaptor between UPF1
and Stau1. To this end, we expressed and puriﬁed full-length
Stau1 with an N-terminal GST tag and performed pulldown
assays of GST-Stau1 with UPF2. Surprisingly, UPF2 co-
precipitated with GST-Stau1 in stoichiometric amounts, suggest-
ing a robust interaction between the two proteins (Fig. 1e, lanes 1,
3, and 4). Furthermore, co-immunoprecipitation (co-IP) assays of
Flag-Stau1 with full-length UPF1 and UPF2 from HEK 293T cells
showed that Stau1 interacts with UPF2 in an RNA-independent
manner and that binding of Stau1 to UPF1 is enhanced in the
presence of UPF2 (Supplementary Fig. 1d). In order to identify
the Stau1-binding region of UPF2, we designed a series of UPF2
constructs where each domain was systematically deleted (Fig. 1a)
and tested the interaction of these truncated proteins with GST-
Stau1. We found that the third MIF4G domain of UPF2
(MIF4G3) was both necessary and sufﬁcient for binding Stau1
(Fig. 1e, lanes 4 and 5). Incidentally, the MIF4G3 domain is also
the region of UPF2 that mediates its interaction with the core
NMD factor, UPF3, and the eukaryotic release factor eRF3,
suggesting that this domain acts an interaction platform in many
functional pathways29–32. Taken together, our results indicate
that UPF2 acts as an adaptor between Stau1 and UPF1 and might
play an important role in the recruitment of UPF1 to the SMD
pathway.
The dsRBDs of Stau1 mediate its interaction with UPF2. The
human Stau1 protein exists as multiple isoforms in cells. The two
major isoforms, referred to as Stau163 and Stau155 in the litera-
ture, are identical in their domain structure and organization and
differ only in the length of the N-terminal extension preceding
the ﬁrst structured domain, dsRBD223. GST-pulldown assays of
GST-UPF2s with the two major Stau1 isoforms (Fig. 2a, Stau1
and Stau1s for the 577- and the 496-residue proteins, respectively)
revealed that both isoforms bound UPF2 with equal afﬁnity,
therefore indicating that the UPF2-binding site lies within the
structured core of Stau1 (Fig. 2b, lanes 1 and 2). To map the
UPF2-binding site, we created a series of N-terminal deletion
constructs of Stau1, removing successive domains each time
(Fig. 2a). Removal of dsRBD2 had no effect on UPF2 binding,
whereas deletion of dsRBD3 was sufﬁcient to abolish the inter-
action between Stau1 and UPF2 (Fig. 2b, compare lane 3 with
lanes 4–6). This suggests that the dsRBD3 domain is necessary for
mediating the interaction of Stau1 with UPF2.
We attempted to purify the individual dsRBDs of Stau1 in
order to precisely locate the UPF2 interaction domain. However,
the dsRBD3 and 4 domains were prone to aggregation and could
only be puriﬁed as fusions with dsRBD2. The resultant constructs,
Stau1 dsRBD2-3 and dsRBD2-3-4, were used for GST-pulldown
assays. We found that the dsRBD2-3 protein was not sufﬁcient to
recapitulate binding of Stau1 to UPF2 (Fig. 2c, lane 3). However,
addition of the dsRBD4 domain rescues binding of the protein
(Stau1 dsRBD2-3-4) to UPF2 (Fig. 2c, compare lane 6 with 3).
Although the dsRBD3 domain of Stau1 is essential for mediating
its interaction with UPF2, it appears that the dsRBD4 domain
might contribute additional binding sites to assemble a stable
interaction platform.
Since the dsRBD3 and 4 domains of Stau1 cooperatively bind
RNA26, we conjectured that tandem dsRBDs containing UPF2-
binding sites are also a requirement for the interaction of Stau1
with UPF2. To test this hypothesis, we engineered constructs of
Stau1 dsRBD2-3 fused to a heterologous dimerization domain
(that of the nuclear factor-κB (NF-κB) transcription factor p5033,
indicated by DD) or to its native dimerization module (dd),
comprising the SSM and dsRBD5 domains (Fig. 2a). GST-
pulldown assays of these Stau1 constructs with GST-UPF2s
demonstrated that, in contrast to Stau1 dsRBD2-3, the dimeric
proteins were indeed capable of binding UPF2 (Fig. 2c, compare
lanes 3, 4, and 5). Fusion of the dimerization modules to the C
terminus of Stau1 dsRBD2-3-4 also enhanced its binding to UPF2
(Fig. 2c, compares lanes 6, 7, and 8). Consistent with our
observation that deletion of dsRBD2 does not impact the
Stau1–UPF2 interaction, we saw no binding upon fusion of the
heterologous dimerization domain to Stau1 dsRBD2 alone
(Fig. 2c, lane 2). The dimerization domains themselves did not
interact with UPF2 (Fig. 2b, lane 6 and Supplementary Fig. 2c).
Based on our observations, we propose that at least two
interaction domains of Stau1 presented either in cis, as in Stau1
dsRBD2-3-4, or in trans, as in Stau1 dsRBD2-3-DD/dd, are
essential for the formation of a composite interaction platform for
UPF2. Incidentally, we found that UPF1 only binds Stau1 in the
presence of its native dimerization module or a heterologous
dimerization domain. The binding site for UPF1 resides within
the Stau1 dsRBD3 and 4 domains, thereby overlapping with its
UPF2- and RNA-binding regions (Supplementary Fig. 2d). The
pivotal role of UPF2 in bridging the interaction between Stau1
and UPF1 is evident from our SEC analysis where the Stau1
dsRBD2-3-DD protein, which comprises the primary UPF2-
binding domain (dsRBD3), but lacks part of the UPF1-binding
site (dsRBD4), was still capable of engaging UPF1 in the presence
of UPF2 (Fig. 2d).
Stau1 dimerization impacts recruitment of the UPF proteins.
Full-length Stau1 dimerizes in solution and in cells34, although
the proportion of dimer in solution is relatively low (Fig. 3a,
compare peaks 1 and 2). Previous reports and our multi-angle
light scattering (MALS) data suggest that the protein is in rapid
equilibrium between the monomeric and dimeric forms (Sup-
plementary Fig. 3a). Dimerization of Stau1 was shown to be
Fig. 1 Interactions of Stau1 with UPF1 and UPF2. a Schematic representation of the domain arrangements of human UPF1, UPF2, and Stau1. Globular
domains are shown as rectangles and ﬂexible linkers and low-complexity regions are denoted as lines. The helicase core of UPF1 consisting of the two RecA
domains is colored yellow and the cis-inhibitory CH domain is in green. The three MIF4G domains of UPF2 are shown in shades of blue, while the C-
terminal UPF1-binding region of UPF2 is shown as a hatched box. The four dsRNA-binding domains (dsRBDs) and the tubulin-binding domain (TBD) of
Stau1 are in purple. The Staufen-swapping motif (SSM, hatched box) together with dsRBD5 comprises the Stau1 dimerization module (dd). The constructs
of UPF1 and UPF2 used in this study are indicated. b RNA-dependent ATPase activity of UPF1 in the presence of UPF2 or Stau1, performed using an
enzyme-coupled phosphate detection assay. The data points and their error bars represent the mean values and standard deviation (s.d.) from three
independent experiments. c GST-pulldown assays of Stau1 and UPF2 with GST-UPF1CH as a bait. GST serves as a negative control. The top and bottom
panels indicate input and precipitate in this and all other GST-pulldown experiments. Binding of Stau1 to UPF1CH is ~3-fold weaker than the binding of UPF2
to UPF1CH. d GST-pulldown assays of UPF1 and Stau1 in the absence and presence of UPF2. GST-UPF1 and UPF1CH are used as baits while GST serves as a
negative control. The presence of UPF2 strengthens the interaction of Stau1 with UPF1 and UPF1CH by ~3-fold. e GST-pulldown assays to determine the
Stau1-binding region of UPF2. Binding of GST-Stau1 to different UPF2 constructs spanning the entire protein identiﬁed the UPF2-MIF4G3 domain as the
Stau1-binding site. The corresponding negative controls using GST as bait is shown in Supplementary Fig. 1c. The asterisk (*) indicates contaminants in d, e.
The source data for this ﬁgure are provided as source data ﬁles
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essential for mediating SMD, possibly by augmenting its binding
to UPF127. In light of our results implicating UPF2 in bridging
the Stau1–UPF1 interaction, we set out to investigate the role of
Stau1 dimerization in reconstituting a stable UPF1-UPF2-Stau1
ternary complex. First, we tested the ability of the Stau1 dsRBD2-
3-4 protein (comprising both UPF1- and UPF2-binding sites, but
lacking the dimerization module) to form a stable complex with
UPF1 and UPF2. MALS analysis indicated that the Stau1
dsRBD2-3-4 protein is a monomer in solution (Supplementary
Fig. 3a). Equi-molar amounts of the three proteins were mixed
a c
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Fig. 2 Tandem dsRBDs of Stau1 form a composite binding platform for UPF2. a Schematic representation of the Stau1 constructs designed to map the
UPF2-binding site. The orange rectangle labeled “DD” represents the dimerization domain of the NF-κB transcription factor p5033, connected to Stau1 via a
4-residue linker. The native dimerization module of Stau1, comprising the SSM and dsRBD5 domains, is denoted by “dd”. b, c GST-pulldown assays of the
Stau1 constructs with GST-UPF2s as a bait. Negative controls using GST are shown in Supplementary Fig. 2a, b. The dsRBD3 domain of Stau1 is necessary
for binding UPF2, although a strong interaction between UPF2 and Stau1 requires the presence of at least two such binding-competent dsRBDs.
Contaminants that co-puriﬁed with GST-UPF2 are indicated by asterisks (*). d Analytical size-exclusion chromatography (SEC) depicting stable complex
formation between UPF1, UPF2s, and a Stau1 construct containing only the UPF2-binding site (dsRBD2-3-DD). The terms Abs and Vr denote the
absorbance and retention volume of the proteins in this and all subsequent chromatograms. The exclusion volume of the column is 0.8 mL. The
corresponding SDS-PAGE analysis of the peak fractions (indicated on the chromatogram) is shown on the right. Formation of a stable Stau1-UPF complex is
mediated by UPF2. The source data for this ﬁgure are provided as a source data ﬁle
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and analyzed by analytical SEC, together with the UPF1-UPF2
complex and the individual Stau1 protein. Stau1 dsRBD2-3-4
associated in a sub-stoichiometric manner with the UPF proteins
and failed to form a stable ternary complex with UPF1 and UPF2
(Fig. 3b, peaks 1 and 2 in the SEC proﬁle and lanes 1 and 2 of the
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) analysis). In contrast, the dimeric protein Stau1 dsRBD2-
3-4-DD was capable of stable association with UPF1 and UPF2,
as indicated by a lower retention volume of the ternary complex
compared to that of the UPF1-UPF2 complex (Fig. 3c, compare
peaks 1 and 2 of the SEC proﬁle). Furthermore, equal amounts of
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a stoichiometry assembly of the ternary complex (Fig. 3c, SDS-
PAGE analysis, lane 1). Fusion of the native dimerization domain
(dd) to the Stau1 dsRBD2-3-4 construct resulted in a protein that,
like its full-length counterpart, is in rapid equilibrium between a
dimer and a monomer (Supplementary Fig. 3a). The Stau1
dsRBD2-3-4-dd protein also engaged UPF1 and UPF2 in a stable
interaction, although a signiﬁcant fraction of the protein was not
involved in complex formation (Fig. 3d, peaks 1 and 2 of the SEC
proﬁle and lanes 1 and 2 of the corresponding SDS-PAGE ana-
lysis). This is in agreement with our observations from GST-
pulldown assays where the stronger heterologous dimerization
domain had a more signiﬁcant effect on augmenting UPF2
binding to Stau1 than the weaker native dimerization module
(Fig. 2c, compare lanes 4 and 7 with 5 and 8, respectively). These
data indicate that dimerization of Stau1 is essential for the stable
recruitment of UPF1 and UPF2, and consequently, for all
downstream functional effects mediated by the UPF proteins.
Domains that are not directly involved in protein–protein inter-
actions within the ternary complex, such as the TBD of Stau1 and
the MIF4G1-2 domains of UPF2, did not hinder the assembly of
the complex (Supplementary Fig. 3c, d).
Topology of a UPF1-UPF2-Stau1 ternary complex. Our bio-
chemical studies suggest that UPF2 acts as an adaptor in the SMD
pathway, connecting a Stau1 dimer to the UPF1 helicase. To gain
insight into the spatial proximity of the individual proteins within
the complex, we performed cross-linking mass spectrometry (MS)
using the long-range chemical cross-linker BS3 (bis(sulfosucci-
nimidyl)suberate). A long spacer arm separates the two functional
groups of BS3, allowing it to cross-link lysine residues up to 30 Å
apart in three-dimensional space. The analysis was performed on
an in vitro reconstituted complex, consisting of UPF1 and the
minimal interaction domains of UPF2 and Stau1 (UPF2s and
Stau1 dsRBD2-3-4-DD, respectively). In line with our biochem-
ical data, we found extensive cross-links between Stau1 and UPF2
and relatively few cross-links between Stau1 and UPF1 (Fig. 4a).
Strikingly, a majority of cross-links between Stau1 and UPF2
mapped to the MIF4G3 domain of UPF2. Cross-links were also
found between UPF2-MIF4G3 and the helicase core of UPF1,
despite complex formation between the UPF proteins being dic-
tated by interactions between the UPF1CH domain and the
U1BD of UPF2. Cross-linking mass spectrometric analysis of the
UPF1-UPF2s complex also yielded very few cross-links between
the UPF1CH domain and the UPF2 C-terminus (Supplementary
Data 1), suggesting that most lysines within the CH domain are
not in a favorable position to carry out the cross-linking reaction.
The residues of UPF2 that cross-linked to UPF1 (K781 and K790)
and Stau1 (K785 and K863) mapped to the outer convex surface of
the MIF4G3 domain, distinct from its UPF3-binding site (Fig. 4b,
left panel, brown spheres). A surprisingly high number of intra-
links were found for the Stau1 protein, in comparison to UPF1
and UPF2. We suggest that at least some of these intra-links
represent cross-links between two Stau1 monomers, although our
analysis did not allow us to distinguish between the individual
monomers within the ternary complex.
Using the information on interacting surfaces obtained from
our cross-linking mass spectrometric analysis and previously
determined X-ray crystal structures, we generated a three-
dimensional model of the UPF1-UPF2-Stau1 ternary complex
bound to dsRNA using the Haddock 2.2 webserver35. From the
predicted model, it emerges that the MIF4G3 domain of UPF2 is
a central platform around which the UPF1-UPF2-Stau1 complex
is assembled (Fig. 4c). Interaction of the UPF1CH domain with
the UPF2 C-terminus appears to position the UPF2-MIF4G3
domain in close proximity to the RecA1 domain of UPF1. In this
position, the MIF4G3 domain can engage with the dsRBD3 and 4
domains of Stau1, while the N- and C-termini of Stau1 can wrap
around the UPF1 RecA domains and the UPF2 C terminus.
Interestingly, the residues of dsRBD3 and dsRBD4 that cross-
linked to UPF2 map to a solvent-exposed surface of Stau1 that is
distal to its RNA-binding interface (Fig. 4b, right panel, pink
spheres), implying that binding of UPF2 to Stau1 does not affect
its interaction with RNA. Our results suggest that the topology of
this ternary complex is compatible with RNA binding, although
certain rearrangements might occur upon interaction of the
complex with RNA.
The role of UPF2 in assembling an SMD-competent mRNP.
Formation of an mRNP consisting of Stau1 and UPF1 is
imperative for correctly positioning the helicase with respect to
the SBS, such that it can effectively carry out its 5′–3′ unwinding
activity. We hypothesize that UPF2 facilitates the recruitment of
UPF1 to the Staufen-bound SBS, thereby leading to the assembly
of an mRNP, and also enhances UPF1 catalytic activity in this
context. To this end, we performed GST-pulldown assays to
dissect the interactions between Stau1 and the UPF proteins in
the presence of dsRNA, using GST-UPF1CH as bait. The dsRNA
was labeled at its 5′ end with 32P to enable its detection by
autoradiography. Consistent with the weak interaction between
Stau1 and UPF1 (Fig. 5a, lanes 1 and 2), the amount of dsRNA
co-precipitated with GST-UPF1CH was negligible (Fig. 5a, lower
panel). In contrast, the robust interaction between Stau1 and
UPF2 led to co-precipitation of signiﬁcant amounts of dsRNA
with GST-UPF2s (Fig. 5a, lanes 3 and 4). The addition of dsRNA
did not appear to perturb the interaction between UPF2 and
Stau1, validating our observations from cross-linking MS, where
UPF2 was found to cross-link to a Stau1 surface distal to its RNA-
binding interface (Fig. 4b, right panel). The strong binding
between UPF2 and Stau1 is instrumental in recruiting UPF1 to
dsRNA-bound Stau1, as indicated by the stoichiometric co-
elution of the UPF2 and Stau1 proteins, as well as the dsRNA
with GST-UPF1CH (Fig. 5a, lane 6). It should be noted that the
CH domain does not interact with RNA in the absence of the
UPF1 helicase core. These data suggest that the assembly of an
mRNP encompassing Stau1 and UPF1 is driven by the con-
comitant interaction of UPF2 with SBS-bound Stau1 and UPF1.
Fig. 3 Stau1 dimers promote the assembly of Stau1-UPF ternary complexes. a Analytical SEC and corresponding SDS-PAGE analysis illustrating the
monomer and dimer populations of full-length Stau1. b–d Analytical SEC to assess the ability of monomeric and dimeric Stau1 proteins (shown in a) to form
a stable complex with UPF1 and UPF2s. Left: overlay of chromatograms of the three-component mixture (UPF1-UPF2-Stau1, in pink), the UPF1-UPF2
complex (blue), and the indicated Stau1 protein (purple); right: corresponding SDS-PAGE analyses of the peak fractions of each experiment. The detailed
SDS-PAGE analyses of the runs are shown in Supplementary Fig. 3b. Monomeric Stau1 comprising the UPF1 and UPF2 interaction domains does not
adequately engage the proteins to form a stoichiometric complex. Fusion of a heterologous or the native dimerization domain to the same Stau1 construct
leads to stoichiometric binding of the resultant Stau1 proteins to UPF1 and UPF2. Since the identity of the heterologous dimerization domain (DD) does not
affect the behavior of Stau1, a fusion of Stau1 with the dimerization domain of the Hsp70-interacting protein (Hip)54 was used for these experiments to
achieve clear separation of the proteins by SDS-PAGE. The source data for this ﬁgure are provided as a source data ﬁle
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We next performed RNA-dependent ATPase assays to assess
the catalytic activity of UPF1 in complex with Stau1 and UPF2.
As mentioned earlier, Stau1 alone was incapable of stimulating
the ATPase activity of UPF1 (Fig. 5b, compare yellow and purple
traces, and Supplementary Fig. 4a). However, in the presence of
Stau1 and UPF2s, UPF1 exhibited an increase in catalytic activity
that is comparable to the increase observed upon addition of
UPF2s alone (Fig. 5b, compare yellow, pink, and blue traces, and
Supplementary Fig. 4a). Therefore, stimulation of UPF1 ATPase
activity in context of the Staufen-mRNP can be attributed to the
presence of UPF2 in this complex. Since the binding of UPF2 to
UPF1 remained unchanged in the presence of Stau1 (Supple-
mentary Fig. 4b), the activation of UPF1 in the presence of
Stau1–UPF2 did not exceed that by UPF2 alone.
Finally, in order to ascertain the contribution of UPF2 in
mediating mRNA degradation via SMD, we took advantage of a
recent study by Sakurai et al.,36 where the RNA-editing enzyme
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contain dsRNA structures in their 3′-UTR by binding to them
and protecting them from SMD. Down-regulation of ADAR1 in
cells leads to an increased binding of Stau1 to the target mRNA
and a subsequent reduction in mRNA levels due to SMD. Studies
from Yang and co-workers4,5,36,37 also showed that ADAR1 binds
a subset of Stau1 targets. We performed small interfering RNA
(siRNA) knockdowns of ADAR1 alone and in combination with
either UPF2 or Stau1 (as a positive control for SMD) in U2OS
cells and analyzed the levels of four mRNA transcripts, known to
bind both ADAR1 and Stau14,5,36,37, by quantitative reverse
transcription PCR (RT-qPCR) (Fig. 5c). The extent of knock-
down of each transcript was also veriﬁed by RT-qPCR
(Supplementary Fig. 4c). Knockdown of ADAR1 led to a
signiﬁcant reduction in the levels of the XIAP and MDM2
transcripts and a more modest reduction in CCNG1 and RAD51
levels. However, consistent with published data, a combined
knockdown of Stau1 and ADAR1 led to an increase in target
mRNA levels due to the absence of SMD in these cells. We found
that a knockdown of UPF2 in combination with ADAR1 also led
to an increase in mRNA levels, suggesting that SMD was
suppressed in the absence of UPF2 (Fig. 5c, compare blue and
purple bars). These observations underline the importance of
UPF2 in assembling an SMD-competent mRNP in cells and
highlight it as a major player of the SMD pathway.
Discussion
The involvement of RNA helicases in pathways of mRNA decay is
a well-established theme in biology38. This includes the Ski2 and
Mtr4 helicases that are associated with the cytoplasmic and
nuclear exosomes, Dhh1 (DDX6/RCK in humans) that mediates
mRNA decapping, and a number of helicases such as DHX34,
MOV10, and UPF1 that are involved in the NMD pathway39–42.
In addition to NMD, UPF1 has been implicated in several other
mRNA degradation pathways such as SMD, histone mRNA
decay, and Regnase-1-mediated decay10,43,44. Although the cata-
lytic activity of UPF1 was shown to be essential for mediating
mRNA decay in these diverse pathways, other NMD factors that
play a role in post-translational modiﬁcation, activation, and
recruitment of UPF1 were not identiﬁed in these pathways. In the
SMD pathway, these roles were believed to be fulﬁlled by the
Stau1 protein. The prevailing model of SMD suggests that direct
interactions between Stau1 and UPF1 recruit the helicase to the
SBS of target mRNA and activate it so as to remodel the mRNP in
preparation for degradation8. Our in vitro biochemical studies
using puriﬁed proteins have revealed an unexpected role for the
core NMD factor UPF2 in the SMD pathway. UPF2 engages in
strong interactions with both Stau1 and UPF1, thereby acting as
an adaptor between the two hitherto known SMD factors. Using
cross-linking MS, we have charted a map for the spatial proximity
of three proteins within the ternary complex. Furthermore, we
demonstrate the formation of an mRNP comprising UPF1, UPF2,
Stau1, and dsRNA and show that UPF1 can be robustly activated
by UPF2 in the presence of Stau1, which is a prerequisite for its
function in SMD. Indeed, knockdown of UPF2 appears to repress
SMD in cells, emphasizing its involvement in this pathway
(Fig. 6). Interestingly, a previous study that ascertained a role for
UPF1 in SMD did not identify UPF2 as an adaptor between the
two proteins or as an essential factor for this pathway10.
NMD and SMD are competitive pathways in cells11. This was
presumed to be due to binding of UPF2 and Stau1 to the same
region (CH domain) of UPF1. However, our studies indicate that
despite the overlap in the binding site, interactions of Stau1 and
UPF2 to UPF1 are not mutually exclusive with each other. On the
contrary, binding of UPF2 to UPF1 augments the Stau1–UPF1
interaction. Therefore, the competition between the two pathways
cannot be attributed to competition in binding of UPF2 and
Stau1 to UPF1. Furthermore, the binding of UPF1 to Stau1 is
signiﬁcantly weaker than to UPF2, suggesting that Stau1 is
unlikely to displace UPF2 from UPF1. Interestingly, UPF2
binds to Stau1 through its MIF4G3 domain, which is also
the binding site of the core NMD factor UPF329. Although our
cross-linking mass spectrometric data suggest that the surface
of the UPF2-MIF4G3 domain that contacts Stau1 is distinct
from its UPF3-binding site, it is possible that steric hindrances
prevent UPF2 from simultaneously interacting with UPF3 and
Stau1. We anticipate that the observed competition between the
NMD and SMD pathways is not because of competition in
binding to UPF1, but rather because of partial overlap in the
UPF2-binding sites.
It is still unclear how UPF2 is speciﬁcally recruited to the target
mRNA prior to degradation. Both Stau1 and UPF1 are RNA-
binding proteins and bind ds- and ss-RNA throughout the length
of the transcript5,45. On the other hand, UPF2 does not bind
RNA and must be speciﬁcally recruited through its interactions
with the RNA-binding factors. However, it is important that this
recruitment occurs at a precise time-point in the pathway, as early
activation of UPF1 would lead to remodeling of the mRNP and
premature mRNA decay. The interactions mediated by UPF2 in
the context of NMD provide some clues as to how the timely
recruitment of UPF2 to SMD might be achieved. Stalling of the
ribosome on a stop codon leads to recruitment of the eukaryotic
release factors 1 and 3 (eRF1/3)46. Studies by Lopez-Perrote
et al.30 showed that UPF2 binds eRF3 using its MIF4G3 domain
and that this interaction is mutually exclusive with its binding to
UPF3. In light of these data, it is tempting to speculate that, in
NMD, UPF2 is delivered or handed over from the translation
termination complex to UPF3, which is bound to the exon-
junction complex present downstream of the premature termi-
nation codon. Since SMD also relies upon the presence of an
upstream termination codon, a similar hand-over mechanism can
be envisaged for recruiting UPF2 to the Stau1-bound mRNA in
this pathway.
Fig. 4 Topology of a UPF1-UPF2-Stau1 complex. a Linkage map showing the identiﬁed pairwise cross-links between proteins in the Stau1-UPF ternary
complex, generated by the program xiNET53. The bars for each protein depict the construct used to reconstitute the ternary complex for the cross-linking
mass spectrometry analysis. The UPF1 and UPF2 proteins are colored as in Fig. 1. The dsRBD3 and 4 domains of Stau1 and the fused dimerization domain
(Hip) are in pink, purple, and orange, respectively. Intra-links within each protein are shown as gray solid lines; inter-links between UPF1 and UPF2 and
between a Stau1 monomer to UPF1/UPF2 are shown as black solid lines. Inter-links are only shown with one Stau1 monomer, as the two molecules within
the dimer cannot be distinguished in our study. A list of intra-and inter-links for each protein can be obtained from Supplementary Data 1. b Previously
determined X-ray crystal structures of the UPF2-UPF3 complex (left panel) and Stau1 dsRBD3-4 bound to dsRNA (right panel) with the cross-linked
residues highlighted in each case. Residues of UPF2 that cross-link to Stau1 and UPF1 are shown as brown spheres (left panel) while those of Stau1 that
cross-link to UPF2 are depicted as pink spheres (right panel). The domains of UPF2 and Stau1 are colored as above, while UPF3 and dsRNA are shown as
gray and black cartoons, respectively. c Predicted structural model of the UPF1-UPF2-Stau1 ternary complex generated using the Haddock 2.2 Prediction
server35. Available X-ray crystal structures and distance restraints between pairwise cross-linked residues were used as inputs for prediction. The protein
domains, cross-linked residues, and inter-links are depicted as described above
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In contrast to the above-mentioned work, recent studies
reported the direct interaction of UPF3 with the eRF1/3 complex
in the absence of UPF2, leading to delayed translation termina-
tion in NMD47. Given that human Stau1 was shown to associate
with ribosomes, it is possible that the molecular determinant
linking SMD to translation termination is Stau1 and that UPF2 is
recruited at a later stage in the pathway25.
Previous studies from Gleghorn et al.27 suggest that dimer-
ization of Stau1 is essential for its function in SMD, presumably
by boosting its interaction with UPF1. Our studies demonstrate
the need for a Stau1 dimer in stably interacting with UPF1 and
UPF2, rationalizing the observed importance of dimerization in
SMD. However, Stau1 forms only weak dimers in solution due to
domain-swapping interactions between its dsRBD5 domain and
the Staufen-swapping motif (SSM), collectively referred to as the
dimerization module. Very recently, Lazzaretti et al.26 showed
that the Stau1 dimerizes upon binding to dsRNA, independent of
its dimerization module, implying that the intrinsically weak
dimer might be strengthened upon binding of Stau1 to its target
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Fig. 5 A pivotal role for UPF2 in the SMD pathway. a GST-pulldown assays of Stau1 with GST-UPF1CH and GST-UPF2s in the absence and presence of
dsRNA. The dsRNA was partially labeled with 32P to enable its detection by autoradiography (lower panels of input and precipitate). As before, proteins
were detected by staining with Coomassie Brilliant Blue (CBB). The co-precipitation of dsRNA with UPF1 is signiﬁcantly enhanced in the presence of UPF2
due to strong interactions between UPF2 and Stau1 in the presence of dsRNA. b RNA-dependent ATPase of UPF1 in complex with UPF2 and Stau1,
performed using an enzyme-coupled phosphate detection assay. The ATPase activity of UPF1 in the presence of either UPF2 or Stau1 served as controls.
The data points and their error bars represent the mean values and standard deviation (s.d.) from three independent experiments. c Quantitative (q) PCRs
to determine levels of known ADAR1/Stau1 targets, XIAP,MDM2, CCNG1, and RAD51, upon knockdown of SMD proteins in U2OS cells. Target mRNA levels
were normalized to that of the GAPDH transcript in every case. The control siRNA refers to a scrambled sequence that does not speciﬁcally target any
transcript. Knockdown of UPF2 in combination with ADAR1 leads to increase in the levels of SMD target. The ADAR1/Stau1 knockdown was performed as a
positive control. The data were obtained from duplicates of the indicated number of biological replicates, with error bars denoting the standard deviation (s.
d.) between the biological replicates. Individual data points are represented as solid circles, while the mean of each data series is represented as a column.
The differences in mRNA levels between the ADAR1 knockdown and the ADAR1/UPF2 or the ADAR1/Stau1 knockdown samples is signiﬁcant, as indicated
by the p values obtained from unpaired t tests. The source data for a, b are provided as a source data ﬁle
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other dsRNA-binding proteins such as NF90 and the adenosine
deaminase ADAR248,49. However, unlike NF90, which has a
separate hetero-dimerization domain, Stau1 uses the same
domains (dsRBD3 and 4) to interact with RNA as well as the UPF
proteins. Although certain atypical dsRBDs have been shown to
interact with both proteins and dsRNA, the binding events were
mutually exclusive50. To the best of our knowledge, Stau1
represents the ﬁrst example of a dsRBD that is capable of con-
comitant binding to dsRNA and a protein factor. Together with
the aforementioned studies on dimerization and RNA binding,
our studies also highlight the scope of interactions mediated by
dsRBDs and their versatility in cellular functions.
In summary, we have identiﬁed the NMD factor UPF2 as the
pivotal component that is essential for recruiting the RNA heli-
case UPF1 to a Staufen-mRNP, activating it within this complex
and mediating SMD (Fig. 6). Our ﬁndings highlight the
mechanistic similarities between NMD and SMD and point to an
extensive cross-talk between these, and possibly other UPF1-
dependent pathways in cells. Nevertheless, whether UPF2 is
involved in every such pathway and how it might be recruited to
these pathways remains a topic for further studies.
Methods
Protein expression and puriﬁcation. All human UPF1, UPF2, and Stau1 con-
structs used in this study were expressed as 6×-His, His-GST, or His-Thioredoxin
(Trx) fusions (cleavable with TEV or 3C protease, please refer to Supplementary
Table 1) in Escherichia coli BL21 (DE3) STAR pRARE cells at 18 °C for at least
15 h. Cells expressing recombinant proteins were lysed using buffer A (20 mM
Tris-HCl, pH 7.5, 10 mM imidazole, 1 mM MgCl2, 1 µM ZnCl2, and 10% glycerol)
supplemented either with 500 mM NaCl (for UPF1 and UPF2) or 1M NaCl (for
Stau1), protease inhibitors, and DNase I. The proteins were enriched from the
crude lysate by Ni2+-afﬁnity chromatography and eluted from the Ni2+-NTA resin
using buffer A supplemented with an additional 240 mM imidazole and 150 mM
NaCl (for UPF1 and UPF2) or 1 M NaCl (for Stau1). The afﬁnity tags on UPF1 and
UPF2 were not removed in any case except for His-GST-UPF2 (126–1227), where
the N-terminal His-GST tag was removed by cleavage with TEV protease. The His-
Trx tags of the Stau1 constructs were cleaved by 3C protease during overnight
dialysis at 4 °C against dialysis buffer (20 mM Tris-HCl, pH 7.5, 400 mM NaCl,
10% glycerol).
All proteins were subjected to a further puriﬁcation step using a HiTrap
Heparin Sepharose HP column (GE Healthcare). SEC (Superdex 200 column, GE
Healthcare) was performed in buffer B (20 mM HEPES, pH 7.5, 150 mM NaCl, 2
mM dithiothreitol (DTT), 5% glycerol, 1 mM MgCl2, and 1 µM ZnCl2) as a ﬁnal
step of puriﬁcation.
To purify a UPF1-UPF2 complex for analytical SEC assays, equi-molar amounts
of puriﬁed UPF1 and UPF2 were mixed and incubated at 4 °C for 16 h, following
which the mixture was injected on a Superdex 200 column in buffer B.
The UPF1-UPF2-Stau1 complex was formed by mixing the puriﬁed UPF1-
UPF2 complex (described above) with Stau1 in a 1:1 molar ratio (considering Stau1
as a dimer). The protein mixture was incubated for 16 h at 4 °C in buffer B
supplemented with 50 mM NaCl (ﬁnal salt concentration of 200 mM NaCl). The
resultant ternary complex was isolated by SEC (Superdex 200 column) in buffer B.
GST-pulldown assays. GST-pulldown assays were done by mixing equal amounts
of bait and prey proteins and diluting the protein mixture to 40 µL in GST-
pulldown buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 10% glycerol, and 0.1%
NP-40). The reaction mixture was incubated at 4 °C for 16 h, following which 12 µL
of a 50% slurry of Glutathione Sepharose resin (GE Healthcare) was added. The
mixture was further supplemented with 200 µL of GST-pulldown buffer and
incubated at 4 °C for 1 h. The beads were extensively washed with GST-pulldown
buffer. Bound proteins were eluted in GST-pulldown buffer supplemented with
20 mM glutathione and analyzed by SDS-PAGE and Coomassie staining. The
intensities of bands in the pulldown gels and the resultant fold change were
quantiﬁed and calculated using the program ImageJ (https://imagej.nih.gov/ij/).
For pulldowns containing dsRNA, we used a chemically synthesized 28-mer, which
was shown by Ramos et al.24 to fold into a 12-bp stem with an intervening tet-
raloop between the two arms of the stem (IBA solutions, 5′-GGACAGCUGUCC
(GUAA)GGACAGCUGUCC-3′, tetraloop sequence is within parentheses). To
check the presence of dsRNA in the input and precipitate samples, the dsRNA was
5′ end labeled with [γ-32P]ATP using T4 polynucleotide kinase. The reactions were
set up in duplicate, and a 1.2-fold molar excess of 28-mer dsRNA (of which
approximately one-third consisted of the labeled dsRNA) was added to the protein
mixture after the overnight incubation. The reaction mixture was further incubated
at 25 °C for 2 h. Bound proteins and RNA were captured and eluted as described
above. One set of eluates were resolved by 7.5% SDS-PAGE and stained with
Coomassie Brilliant Blue to visualize the proteins, while the second set of eluates
were resolved on a 20% Urea-PAGE and analyzed by autoradiography to detect the
labeled dsRNA. The unformatted gels for all GST-pulldown assays, as well as all
other experiments, are provided as a Source Data ﬁle.
Analytical SEC. Seven hundred picomoles of the UPF1-UPF2 complex (described
above) were mixed with 700 pmol of the dimeric Stau1 proteins (dsRBD2-3-DD,






































Fig. 6 A proposed mechanistic model for SMD. UPF2 plays a key role in recruiting UPF1 to the SBS-mRNA and activating the helicase in the context of SMD
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to a ﬁnal volume of 40 µL in buffer A (supplemented with 50 mM NaCl) and
incubated at 4 °C for 16 h. The peak fractions were analyzed by SDS-PAGE, fol-
lowed by staining with Coomassie Brilliant Blue.
ATPase assay. The ATPase activity of UPF1 in the presence of its binding
partners was determined by quantifying the amount of inorganic phosphate
released upon ATP hydrolysis using a coupled colorimetric assay (EnzCheck
Phosphate Kit, Thermo Fisher Scientiﬁc)28. The protein mixtures (see below) were
pre-incubated with 2 μg poly-U RNA, 40 nmol MESG (2-amino-6-mercapto-7-
methylpurine ribonucleoside), and 0.5 U purine-nucleoside phosphorylase in
reaction buffer (50 mM MES, pH 6.5, 50 mM potassium acetate, 5 mM magnesium
acetate, 2 mM DTT) at 30 °C for 20 min. The reaction was initiated by the addition
of ATP to a ﬁnal concentration of 1 mM. Inorganic phosphate released from ATP
hydrolysis reacted with MESG to produce 2-amino-6-mercapto-7-methylpurine,
which was detected by measuring absorbance at 360 nm on an Inﬁnite M1000 Pro
(Tecan). The reaction was monitored over a 20 min period at 60-s intervals. The
amount of UPF1 in every experiment was kept constant (6 pmol), and UPF2 was
added in 1.25× excess of UPF1, wherever indicated. In Fig. 1, the full-length Stau1
protein was added in 10× excess of UPF1, while the experiments in Fig. 5 contained
7.5 pmol (1.25× of UPF1) of the dimeric Stau1 proteins. The end point of the
ATPase reaction (20-min time-point) of the UPF1-UPF2 mixture was set to 100%
and all other data points were normalized to this value. The raw data for all ATPase
assays are provided as a Source Data ﬁle.
siRNA knockdown and RT-qPCR analysis. U2OS cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS) (Bio&SELL), 100 U/mL of penicillin, and 100 μg/mL of streptomycin
(Thermo Fisher Scientiﬁc). The siRNAs used for knockdown of ADAR1, Stau1,
and UPF2 were procured from Thermo Fisher Scientiﬁc (see below). Twenty
picomoles of each siRNA (alone or in combinations, as indicated) were transfected
into 0.15 × 106 U2OS cells using Lipofectamine 2000 (Thermo Fisher Scientiﬁc), as
per the manufacturer’s instructions. Total RNA was extracted from U2OS cells 72 h
post transfection using RNATri (Bio&SELL). Two hundred nanograms of total
RNA was used for gene-speciﬁc complementary DNA synthesis by the MLV-
reverse transcriptase (Qiagen). Quantitative PCRs (qPCRs) were performed using
the PowerUp SYBR Green Master Mix (Thermo Fisher Scientiﬁc) on a Stratagene
Mx3005P instrument. The data represent the mean of duplicates of three biological
replicates, while the error bars denote the standard deviations. Unpaired t tests
were performed to calculate the p values, with the signiﬁcance threshold set at 0.05.
The qPCR primers used in this study are described in Supplementary Table 2.
The following siRNAs used in this study were obtained from Thermo Fisher
Scientiﬁc: ADAR1 (catalog # S1008), UPF2 (catalog # S24948), and Stau1 (catalog #
S13547). The control siRNA had the following sequence:
UUUGUAAUCGUCGAUA CCC-dTdT. The U2OS and HEK 293T (used for co-
IP assays, see below) cell lines were a gift from Florian Heyd and were routinely
tested for mycoplasma contamination in the course of the study. Cell lines showed
the expected morphology and were not authenticated by other methods.
Cross-linking MS of the UPF-Stau1 complex. Ten micrograms of aliquots of the
protein complexes (UPF1-UPF2-Stau1 and UPF1-UPF2) were initially cross-linked
with 0.2, 0.5, 1, and 2 mM BS3 (Thermo Scientiﬁc) to optimize the minimum
concentration of BS3 necessary to achieve efﬁcient cross-linking. The ﬁnal cross-
linking reaction was carried out with 0.2 mM BS3 for 30 min at room temperature
and quenched with 50 mM Tris. Samples were separated by SDS-PAGE (NuPAGE
4–12% gradient gel, Invitrogen). The cross-linked complex was cut out of the gel
and separated into three pieces. Excised gel pieces were then subjected to in-gel
tryptic digest51. Samples were reduced with 10 mM dithiotreitol and alkylated with
55 mM iodacetamide and subsequently digested with trypsin (sequencing grade,
Promega) at 37 °C for 18 h. Extracted peptides were dried in a SpeedVac Con-
centrator and dissolved in loading buffer composed of 4% acetonitrile and 0.05%
triﬂuoroacetic acid. Samples were subjected to liquid chromatography MS on a
QExactive HF-X (Thermo Scientiﬁc). Peptides were loaded onto a Dionex UltiMate
3000 UHPLC+ focused system (Thermo Scientiﬁc) equipped with an analytical
column (75 µm × 300 mm, ReproSil-Pur 120 C18-AQ, 1.9 µm, Dr. Maisch GmbH,
packed in house). Separation by reverse-phase chromatography was done on a 60-
min multi-step gradient with a ﬂow rate of 0.3–0.4 µL/min. MS1 spectra were
recorded in proﬁle mode with a resolution of 120k, maximal injection time was set
to 50 ms, and automatic gain control (AGC) target to 1e6 to acquire a full MS scan
between 380 and 1580m/z. The top 30 abundant precursor ions (charge state 3–8)
were triggered for high-energy collision-induced dissociation fragmentation (30%
normalized collision energy). MS2 spectra were recorded in proﬁle mode with a
resolution of 30k; maximal injection time was set to 128 ms, AGC target to 2e5,
isolation window to 1.4m/z, and dynamic exclusion was set to 30 s. Raw ﬁles were
analyzed via pLink2.3.5 to identify cross-linked peptides, with standard settings
changed as follows: peptide mass: 600–10,000; precursor tolerance: 10 p.p.m.; ﬁxed
modiﬁcation: carbamidomethyl [C] and variable modiﬁcation oxidation: [M]52.
False discovery rate was set to 1% and results were ﬁltered by excluding cross-links
supported by only one cross-linked peptide spectrum match. The interaction
network for the ternary complex was illustrated via xiNET53. The analysis was
carried out with one sample each for the ternary and the UPF1-UPF2 binary
complex (in one and three technical replicates for the ternary and binary com-
plexes, respectively).
The structural model of the UPF1-UPF2-Stau1 ternary complex was generated
using the Haddock 2.2 Prediction server35. Available X-ray crystal structures
(UPF1-UPF2, PDB ID 2WJV; UPF2-UPF3, PDB ID 1UW4; Stau1-dsRNA, PDB ID
6HTU) and distance restraints between pairwise cross-linked residues
(Supplementary Data 1) were used as inputs for prediction. The modeling was
performed in a sequential manner where cross-links between UPF1 and the UPF2-
MIF4G3 were modeled ﬁrst and the resultant output was used to map cross-links
between Stau1 and UPF2-MIF4G3. The outputs with the lowest Haddock score
were considered for analysis. The ﬁnal model was generated by superposing the
UPF2-MIF4G3 domains from both runs.
SEC-MALS assay. Approximately 350 µg of each Stau1 construct was injected
onto a Superdex 200 10/300 column (GE Healthcare) on an Agilent HPLC system
coupled to miniDAWN TREOS (Wyatt Technology, Germany) and Refracto-
Max520 (ERC) detectors. Proteins were eluted using a running buffer containing
20 mM HEPES, pH 7.5, 150 mM NaCl, and 0.02% NaN3. The instrument was
calibrated using bovine serum albumin as a reference. Data recording and analysis
was performed using the ASTRA 6.1.4.25 software (Wyatt Technology, Germany).
The experimentally determined and theoretical molecular weights are mentioned in
Supplementary Fig. 3a.
Co-IP assays. HEK 293T cells were cultured in DMEM supplemented with 10%
FBS (Bio&SELL) and Pen/Strep (Invitrogen). A total of 0.5 × 106 cells/ml were
seeded in a 6-well plate format, and full-length constructs of Flag-Stau1, HA-UPF1,
and HA-UPF2 were co-transfected using polyethyleneimine “Max” (Polysciences
Inc.,Mw 40,000). Transfected cells were incubated at 37 °C and harvested 48 h later.
Cells were lysed using 200 µL of RIPA buffer (10 mM Tris-HCl, pH 7.5, 100 mM
NaCl, 2 mM EDTA, 1% NP-40, supplemented with protease inhibitors) and RNase
A (ﬁnal concentration of 60 µg/mL). Fifteen microliters of anti-Flag M2 resin
(Merck, catalog # A2220) was added to each cell lysate sample and incubated at 4 °
C for 1.5 h. Unbound proteins were washed with RIPA buffer and Flag-tagged baits
and the associated proteins were eluted in non-reducing SDS sample buffer by
incubating at 30 °C for 3 h. The eluted samples were resolved by 10% SDS-PAGE
and then transferred to a PVDF membrane for analysis by western blotting with
mouse anti-HA (1:4000; Covance, catalog # MMS-101R), mouse anti-Flag (1:4000;
Merck, catalog # F1804) antibodies wherever indicated. The secondary antibody
horse anti-mouse horse radish peroxidase (1:4000; Cell Signaling Technologies,
catalog # 7076S) was used to enable detection of tagged proteins by
chemiluminescence.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
A reporting summary for this article is available as a Supplementary Information ﬁle. All
data generated or analyzed during this study are included in this published article and
its Supplementary Information ﬁles, or available from the corresponding author upon
reasonable request. The source data underlying Figs. 1, 2, 3, and 5a, b and Supplementary
Figs. 1, 2, 3, and 4a, b are provided as Source Data ﬁles. The raw data corresponding to
Fig. 4 is provided in Supplementary Data 1.
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